5-HT1A and 5-HT2A ligands with anxiolytic and antipanic-like properties

被引：17
|
作者：
Diouf, O
Carato, P
Depreux, P
Bonte, JP
Caignard, DH
GuardiolaLemaitre, B
Rettori, MC
Belzung, C
Lesieur, D
机构：
[1] INST CHIM PHARMACEUT, F-59006 LILLE, FRANCE
[2] ADIR, F-92415 COURBEVOIE, FRANCE
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1997年 / 7卷 / 20期
关键词：
D O I：
10.1016/S0960-894X(97)10023-3
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
A series of new benzothiazolin-2-one, benzoxazolin-2-one and benzoxazin-3-one derivatives were synthesized and their binding profile at 5-HT1A, 5-HT2A, 5-HT2C as well as D-2 and alpha(1) receptors was determined. All studied compounds displayed high to moderate affinity for both 5-HT1A and 5-HT2A receptor subtypes. Among these, one compound (29) emerged since it exhibited potent antagonist activities at 5-HT1A, 5-HT2A, D-2 and alpha(1) central receptors and showed anxiolytic and antipanic-like effects in mice. 29 is currently undergoing preclinical evaluation. (C) 1997 Elsevier Science Ltd.
引用
收藏
页码：2579 / 2584
页数：6
相关论文
共 50 条
  • [21] A 5-HT1A LIGAND WITH BOTH ANTIDEPRESSANT AND ANXIOLYTIC PROPERTIES
    COTT, JM
    KURTZ, NM
    ROBINSON, DS
    LANCASTER, SP
    COPP, JE
    PSYCHOPHARMACOLOGY BULLETIN, 1988, 24 (01) : 164 - 167
  • [22] 1,4-benzoxazin-3-(4H)-one derivatives and related compounds as 5-HT1A and 5-HT2A receptor ligands;: the effect of the terminal amide fragment on the 5-HT1A/5-HT2A affinity and functional activity
    Mokrosz, MJ
    Kowalski, P
    Kowalska, T
    Majka, Z
    Duszynska, B
    Charakchieva-Minol, S
    Szaro, A
    Tatarczynska, E
    Klodzinska, A
    Chojnacka-Wójcik, E
    POLISH JOURNAL OF PHARMACOLOGY, 1998, 50 (4-5): : 333 - 340
  • [23] Desensitization of 5-HT1A receptors by 5-HT2A receptors in neuroendocrine neurons in vivo
    Zhang, YH
    Gray, TS
    D'Souza, DN
    Carrasco, GA
    Damjanoska, KJ
    Dudas, B
    Garcia, F
    Zainelli, GM
    Hanley, NRS
    Battaglia, G
    Muma, NA
    Van de Kar, LD
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 310 (01): : 59 - 66
  • [24] Altered 5-HT1A and 5-HT2A receptor interactions in anorexia and bulimia nervosa
    Kaye, Walter H.
    Bailer, U. F.
    Frank, G. K.
    Wagner, A.
    Price, J. C.
    Mathis, C. A.
    Meltzer, C. C.
    NEUROIMAGE, 2008, 41 : T155 - T155
  • [25] Ex vivo binding of flibanserin to serotonin 5-HT1A and 5-HT2A receptors
    Scandroglio, A
    Monferini, E
    Borsini, F
    PHARMACOLOGICAL RESEARCH, 2001, 43 (02) : 179 - 183
  • [26] Relationship of 5-HT1A and 5-HT2A activity to behavioral inhibition in healthy women
    Bailer, UF
    Kaye, WH
    Frank, GK
    Henry, SE
    Price, JC
    Meltzer, CC
    Weissfeld, LA
    Wagner, A
    McConaha, CW
    Mathis, CA
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S83 - S83
  • [27] COMPUTATIONAL METHODS IN DETERMINATION OF PHARMACOPHORE MODELS OF 5-HT1A, 5-HT2A AND 5-HT7 RECEPTORS
    Bielenica, Anna
    Kossakowski, Jerzy
    BIULETYN WYDZIALU FARMACEUTYCZNEGO WARSZAWSKIEGO UNIWERSYTETU MEDYCZNEGO, 2010, (01): : 1 - 12
  • [28] Computational Methods in Determination of Pharmacophore Models of 5-HT1A, 5-HT2A and 5-HT7 Receptors
    Bielenica, Anna
    Koziol, Anna E.
    Struga, Marta
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2013, 13 (07) : 933 - 951
  • [29] Interaction of 1,2,4-substituted piperazines, new serotonin receptor ligands, with 5-HT1A and 5-HT2A receptors
    Chilmonczyk, Z
    Cybulski, M
    Iskra-Jopa, J
    Chojnacka-Wójcik, E
    Tatarczynska, E
    Klodzinska, A
    Les, A
    Bronowska, A
    Sylte, I
    FARMACO, 2002, 57 (04): : 285 - 301
  • [30] Synthesis and in vitro pharmacological evaluation of a new series of 5-HT1A 5-HT2A and 5-HT2C receptor ligands containing a norbornene nucleus
    Fiorino, F.
    Severino, B.
    De Angelis, F.
    Perissutti, E.
    Magli, E.
    Frecentese, F.
    Esposito, A.
    Massarelli, P.
    Nencini, C.
    Viti, B.
    Santagada, V.
    Caliendo, G.
    PHARMAZIE, 2009, 64 (09): : 555 - 564
12345